FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA, Austen BioInnovation Sign MOU on Biomaterials

[ Price : $8.95]

FDA and Austen BioInnovation Institute sign a Memorandum of Understanding to collaborate on the safe and effective use of biomater...

FDA Needs More Authority on Drug Shortages: GAO

[ Price : $8.95]

GAO reports that FDA needs more authority to effectively handle drug shortages, and HHS responds for the agency that it supports t...

FDA Clears Critical Diagnostics ST2 Assay

[ Price : $8.95]

FDA clears a Critical Diagnostics 510(k) for the Presage ST2 Assay for use as an aid in assessing the prognosis of patients diagno...

CMS Delays Gift Recording Requirement

[ Price : $8.95]

CMS delays the deadline for drug, medical device, and biologics manufacturers to report payments of more than $10 they make to doc...

Senators Introduce Medical Device Patient Safety Act

[ Price : $8.95]

U.S. senators Chuck Grassley (R-IA), Richard Blumenthal (D-CT) and Herb Kohl (D-WI) introduce the Medical Device Patient Safety Ac...

Federal Reserve Model for Independent FDA?

[ Price : $8.95]

Harvard professor Daniel Carpenter calls for an independent FDA similar to the Federal Reserve to avoid future presidential interf...

FDA Designates Photofrin as Orphan Drug

[ Price : $8.95]

FDA gives Pinnacle Biologics Photofrin orphan drug status as adjuvant therapy for malignant pleural mesothelioma.

Plan B Group to Reopen Lawsuit Against FDA

[ Price : $8.95]

The Center for Reproductive Rights says it will reopen a 2005 lawsuit against FDA for maintaining unnecessary age restrictions on ...

Safety Labeling Changes Approved for 48 Drugs

[ Price : $8.95]

FDA releases safety labeling changes approved in November for 48 drug products, including a new Warning and Precaution for 11 HIV/...

Repros Meets with FDA on Testosterone Drug Study

[ Price : $8.95]

Repros Therapeutics says it met with CDER Divisions of Urologic and Endocrinologic Products to gain input on designing a Phase 3 t...